The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
What interventions should we add to weight reducing diets in adults with obesity? A systematic review of randomized controlled trials of adding drug therapy, exercise, behaviour therapy or combinations of these interventions
Abstract
Background Evidence is needed for the effectiveness of interventions given with reducing diets for obese adults: drug therapy, exercise, or behaviour therapy. Methods We systematically reviewed randomized controlled trials in any language. We searched 13 databases and handsearched journals. Trials lasted 1 year or more. One investigator extracted data and a second checked data extraction. Trial quality was assessed. Results Adding orlistat to diet was associated with weight change for up to 24 months (−3.26 kg, 95% CI, −4.15 to −2.37 kg), and statistically significant beneficial changes were found for total and LDL cholesterol, blood pressure and glycaemic control. Adding sibutramine to diet was associated with a 12 month weight change of −4.18 kg (95% CI, −5.14 to −3.21 kg), and statistically significant beneficial effects on high density lipoprotein cholesterol (HDL) and triglycerides (TGs), but an increase in diastolic blood pressure. Adding exercise to diet, or to diet and behaviour therapy, was associated with improved weight loss for up to 36 months and improvements in HDL, TGs and blood pressure. Adding behaviour therapy to diet, or to diet and sibutramine together, was associated with improved weight loss for up to 18 months. Adding drugs, exercise or behaviour therapy to dietary advice was each associated with similar weight change. Conclusions Adding orlistat, sibutramine, exercise, or behaviour modification to dietary advice can improve long‐term weight loss.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001
Mokdad, A. H., Ford, E. S., Bowman, B. A., Dietz, W. H., Vinicor, F., Bales, V. S., & Marks, J. S. (2003) · JAMA · doi:10.1001/jama.289.1.76 · Cited by 5,866
XENical in the Prevention of Diabetes in Obese Subjects (XENDOS) Study
Torgerson, J. S., Hauptman, J., Boldrin, M. N., & Sjöström, L. (2004) · Diabetes Care · doi:10.2337/diacare.27.1.155 · Cited by 1,915 · cited 1×
“The XENDOS study, published after the time frame of this review, found an association between adding orlistat and reduced incidence of type 2 diabetes in participants with impaired glucose tolerance (Torgerson et al., 2004).”
MethodAvenell, A., Broom, J., Brown, T., Poobalan, A., Aucott, L., Stearns, S., Smith, W., Jung, R., Campbell, M., & Grant, A. (2004) · Health Technology Assessment · doi:10.3310/hta8210 · Cited by 1,041
Self-citationDavidson, M. H., Hauptman, J., DiGirolamo, M., Foreyt, J. P., Halsted, C. H., Heber, D., Heimburger, D. C., Lucas, C. P., Robbins, D. C., Chung, J., et al. (1999) · JAMA · doi:10.1001/jama.281.3.235 · Cited by 947 · cited 3×
“Three studies continued for a second year (Farrell, 1997; Foreyt, 1997; Toornvliet et al., 1997; Davidson et al., 1999; Hauptman et al., 1999; Hauptman et al., 2000; Rossner et al., 2000).”
BackgroundEffect of sibutramine on weight maintenance after weight loss: a randomised trial
James, W. P. T., Astrup, A., Finer, N., Hilsted, J., Kopelman, P., Rössner, S., Saris, W. H. M., & Gaal, L. F. V. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03491-7 · Cited by 817
Hollander, P. A., Elbein, S. C., Hirsch, I. B., Kelley, D., McGill, J., Taylor, T., Weiss, S. R., Crockett, S. E., Kaplan, R. A., Comstock, J., et al. (1998) · Diabetes Care · doi:10.2337/diacare.21.8.1288 · Cited by 654
Wood, P. D., Stefanick, M. L., Williams, P. T., & Haskell, W. L. (1991) · New England Journal of Medicine · doi:10.1056/nejm199108153250703 · Cited by 520
Rössner, S., Sjöström, L., Noack, R., Meinders, A. E., Noseda, G., & Study, O. B. O. T. E. O. O. (2000) · Obesity Research · doi:10.1038/oby.2000.8 · Cited by 476 · cited 3×
“Three studies continued for a second year (Farrell, 1997; Foreyt, 1997; Toornvliet et al., 1997; Davidson et al., 1999; Hauptman et al., 1999; Hauptman et al., 2000; Rossner et al., 2000).”
BackgroundInfluentialOrlistat in the long-term treatment of obesity in primary care settings.
Hauptman, J. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.2.160 · Cited by 367
Kelley, D. E., Bray, G. A., Pi-Sunyer, F. X., Klein, S., Hill, J., Miles, J., & Hollander, P. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1033 · Cited by 314 · cited 1×
“Two other studies published after completing our review have also shown an association between orlistat and reduced need for medication in people with type 2 diabetes (Kelley et al., 2002; Miles et al., 2002).”
Orlistat, a lipase inhibitor, for weight maintenance after conventional dieting: a 1-y study.
Hill, J. O., Hauptman, J., Anderson, J. W., Fujioka, K., O'Neil, P. M., Smith, D. K., Zavoral, J. H., & Aronne, L. J. (1999) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/69.6.1108 · Cited by 287 · cited 1×
“Studies where participants were randomized to treatments after a period of weight loss of 3 months or longer were classified as weight maintenance RCTs, e.g. the STORM trial (James et al., 2000) or the orlistat trial by Hill et al. (1999) and are not discussed here.”
MethodEffect of orlistat in overweight and obese patients with type 2 diabetes treated with metformin
Miles, J. M., Leiter, L., Hollander, P., Wadden, T., Anderson, J. W., Doyle, M., Foreyt, J., Aronne, L., & Klein, S. (2002) · Diabetes Care · doi:10.2337/diacare.25.7.1123 · Cited by 286
Exercise and the maintenance of weight loss: 1-year follow-up of a controlled clinical trial.
Wadden, T. A., Vogt, R. A., Foster, G. D., & Anderson, D. A. (1998) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.66.2.429 · Cited by 119 · cited 1×
“…12 months or longer (Table 3) (Kaplan et al., 1987; Sikand et al., 1988; Wing et al., 1988; Phenix, 1990; Foreyt et al., 1993; Skender et al., 1996; Ashutosh et al., 1997; Polley et al., 1997; Gladis et al., 1998; Wadden et al., 1998; Weinstock et al., 1998; Wing et al., 1998; Wadden et al., 1999).”
ANDERSSEN, S. A., HJERMANN, I., URDAL, P., TORJESEN, P. A., & HOLME, I. (1996) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1996.22848000.x · Cited by 67
Cited by
2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2013.11.004 · Cited by 4,058
Jensen, M. D., Ryan, D. H., Apovian, C. M., Ard, J. D., Comuzzie, A. G., Donato, K. A., Hu, F. B., Hubbard, V. S., Jakicic, J. M., Kushner, R. F., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437739.71477.ee · Cited by 2,735
“The remaining 28 publications were rated good or fair quality and included in the evidence base that was used to formulate the ESs and recommendations (12-39).”
BackgroundGarvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914
Pharmacological Management of Obesity: An Endocrine Society Clinical Practice Guideline
Apovian, C. M., Aronne, L. J., Bessesen, D. H., McDonnell, M. E., Murad, M. H., Pagotto, U., Ryan, D. H., & Still, C. D. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-3415 · Cited by 1,347
Medicare's search for effective obesity treatments: Diets are not the answer.
Mann, T., Tomiyama, A. J., Westling, E., Lew, A.-M., Samuels, B., & Chatman, J. (2007) · American Psychologist · doi:10.1037/0003-066x.62.3.220 · Cited by 1,208
Metadata
- Authors
- Avenell, A., Brown, T. J., McGee, M. A., Campbell, M. K., Grant, A. M., Broom, J., Jung, R. T., & Smith, W. C. S.
- Venue
- Journal of Human Nutrition and Dietetics
- Publisher
- Wiley
- Published
- 2004-07-12
- Volume
- 17
- Issue
- 4
- Pages
- 293-316
- ISSN
- 0952-3871 (ISSN-L)
- 1365-277X
- OpenAlex
- W2166345433
- Cited by
- 186
- References
- 14
- FWCI
- 1.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.